Efficacy of tulathromycin versus enrofloxacin for initial treatment of naturally occurring bovine respiratory disease in feeder calves

Veterinary Therapeutics

Volumn 8, Issue 2, 2007, Pages 127-135

  Robb, Edward J ^a   Tucker, Cassius M ^a   Corley, Lane ^a   Bryson, W Lawrence ^a   Rogers, Karen C ^b   Sturgess, Kynan ^c   Bade, Donald J ^d   Brodersen, Bruce ^e  

^a PFIZER INC   (United States)

^b Vet Res and Consulting Services   (United States)

^c Veterinary Research Associates PLLC   (United States)

^d Microbial Research Inc   (United States)

^e UNIVERSITY OF NEBRASKA LINCOLN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMALIA; BOVINAE;

ANTIINFECTIVE AGENT; DISACCHARIDE; ENROFLOXACIN; HETEROCYCLIC COMPOUND; QUINOLONE DERIVATIVE; TULATHROMYCIN; UNCLASSIFIED DRUG;

ANIMAL; ANIMAL DISEASE; ARTICLE; CATTLE; CATTLE DISEASE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; MULTICENTER STUDY; NEWBORN; RANDOMIZED CONTROLLED TRIAL; RECURRENT DISEASE; SUBCUTANEOUS DRUG ADMINISTRATION; TREATMENT OUTCOME; UNITED STATES; WEIGHT GAIN;

ANIMALS; ANIMALS, NEWBORN; ANTI-BACTERIAL AGENTS; BOVINE RESPIRATORY DISEASE COMPLEX; CATTLE; COLORADO; DISACCHARIDES; FLUOROQUINOLONES; HETEROCYCLIC COMPOUNDS; INJECTIONS, SUBCUTANEOUS; RECURRENCE; TEXAS; TREATMENT OUTCOME; WEIGHT GAIN;

EID: 34748884443     PISSN: 15283593     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. National Agriculture Statistics Services: Cattle and Calves Death Loss. Washington DC, United States Dept. of Agriculture, 1996.
2. Mosier DA: Bacterial pneumonia, bovine respiratory disease update. Vet Clin North Am Food Anim Pract 13(3):483-493, 1997.
3. Nowakowski MA, Inskeep P, Risk JE, et al: Pharmacokinetics and lung tissue concentrations of tulathromycin, a new triamilide antibiotic, in cattle. Vet Ther 5(1):60-74, 2004.
4. Nutsch RG, Skogerboe TL, Rooney KA, et al: Comparative efficacy of tulathromycin, tilmicosin and florfenicol in the treatment of bovine respiratory disease in stocker cattle. Vet Ther 6(2):167-179, 2005.
5. Skogerboe TL, Rooney KA, Nutsch RG, et al: Comparative efficacy of tulathromycin versus florfenicol and tilmicosin against undifferentiated bovine respiratory disease in feedlot cattle. Vet Ther 6(2):180-196, 2005.
6. Rooney KA, Nutsch RG, Skogerboe TL, et al: Efficacy of tulathromycin compared with tilmicosin and florfenicol for the control of respiratory disease in cattle at high risk of developing bovine respiratory disease. Vet Ther 6(2):154-166, 2005.
7. Clinical Laboratory Standards Institute: Performance Standards for Antimicrobial Disk and Dilution Susceptibility Tests for Bacteria Isolated ftom Animals; Approved Standard, ed 2, M31-A2. Wayne, PA, 2002.
8. Brodersen BW: Immunohistochemistry used as a screening method for persistent bovine viral diarrhea virus infection. Vet Clin North Am Food Anim Pract 20(1):85-93; 2004.
9. Rooney KA, Mecuwse DM, Nutsch RG, et al: The efficacy and timing of tulathromycin (Draxxin Injectable Solution) administration for treatment of bovine respiratory disease in calves challenged with Mannheimia haemolytica or managed in a feedlot. Vet Ther, submitted for publication, 2007.
10. Shahriar FM, Clark EG, Janzen E, et al: Coinfection with bovine viral diarrhea virus and Mycoplasma bovis in feedlot cattle with chronic pneumonia. Can Vet J 43(11):863-868, 2002.
11. Haines DM, Martin KM, Clark EG, et al: The immunohistochemical detection of Mycoplasma bovis and bovine viral diarrhea virus in tissues of feedlot cattle with chronic, unresponsive respiratory disease and/or arthritis. Can Vet J 42(11):857-860, 2001.
12. Efficacy of Draxxin* (tulathromycin) Injectable Solution for Treatment of Experimentally Induced Mycoplasma bovis Respiratory Infection in Calves. New York, Pfizer Animal Health, 2007.